- •Dedication
- •Preface
- •Acknowledgements
- •Contributors
- •Contents
- •1. Minimally Invasive Oculoplastic Surgery
- •1.1 General Points
- •1.2 Lower Lid Entropion
- •1.2.1 Introduction
- •1.2.2 Lower Lid Entropion Sutures
- •1.2.3 Lower Lid Entropion Botulinum Toxin
- •1.3 Lower Lid Ectropion
- •1.3.1 Introduction
- •1.3.2 The Royce Johnson Suture
- •1.3.3 The Pillar Tarsorrhaphy
- •1.4 Distichiasis
- •1.4.1 Introduction
- •1.4.2 Direct Excision of Lashes
- •1.5 Ptosis
- •1.5.1 Introduction
- •1.5.3 Anterior Approach – One Stitch Aponeurosis Repair
- •1.5.4 Supramid Brow Suspension
- •1.6 Lid Retraction
- •1.6.1 Introduction
- •1.6.2 Koornneef Blepharotomy
- •1.6.3 Botulinum Toxin
- •1.7 Lid Tumours
- •1.7.1 Mohs’ Micrographic Surgery
- •1.7.2 Lamella Sparing Tumour Excision
- •References
- •2. Minimally Invasive Conjunctival Surgery
- •2.1 Conjunctival Surgery
- •2.2 Conjunctivochalasis
- •2.2.1 Background of the Disease
- •2.2.2 Indication for Surgery
- •2.2.3 Basic Concept of Surgery
- •2.2.4 Surgical Procedure
- •2.2.5 Postoperative Follow-Up
- •2.3 Pterygium
- •2.3.1 Background of the Disease and the Concept of Minimally Invasive Surgery
- •2.3.2 Indication for Surgery
- •2.3.3 Basic Concept of Surgery
- •2.3.4 Surgical Procedures
- •2.3.5 A Biologic Adhesive for Sutureless Pterygium Surgery
- •2.3.6 Postoperative Follow-Up
- •2.4 Limbal and Conjuntival Dermoids
- •2.4.1 Background of the Disease
- •2.4.2 Basic Concept of Surgery
- •2.4.3 Surgical Procedure
- •2.4.4 Postoperative Follow-Up
- •2.5 Strabismus Surgery
- •2.6 Conclusion
- •References
- •3. Minimally Invasive Lacrimal Surgery
- •3.1 Introduction
- •3.1.1 Causes of Stenoses of the Lacrimal Drainage System
- •3.1.3 General Remarks Regarding Surgical Management
- •3.2 Endonasal Endoscopic (Microscopic) Dacryocystorhinostomy (EDCR)
- •3.2.1 Indication for EDCR
- •3.2.2 Surgical Technique
- •3.2.3 Silicone Stenting for EDCR
- •3.2.2.1 Silicone “Cones” (Lacrimal Duct Stent, Bess, Berlin)
- •3.2.4 Use of Mitomycin C for EDCR
- •3.2.5 Post-Operative Care After EDCR
- •3.2.6 Results of EDCR
- •3.3 Endonasal Endoscopic Laser Dacryocystorhinostomy (ELDCR)
- •3.3.1 Indications for ELDCR
- •3.3.2 Contraindications for ELDCR
- •3.3.3 Surgical Technique for ELDCR
- •3.3.4 Potential Problems with ELDCR
- •3.3.5 Post-Operative Care After ELDCR
- •3.3.6 Results of ELDCR
- •3.4 Dacryoendoscopy with Transcanalicular Laserdacryoplasty (TLDP)
- •3.4.1 Indication for TLDP
- •3.4.2 Contraindication for TLDP
- •3.4.3 Surgical Technique for TLDP
- •3.4.4 Results of TLDP
- •3.5 Microdrill Dacryoplasty (MDP)
- •3.5.1 Indication for MDP
- •3.5.2 Contraindication for MDP
- •3.5.3 MDP Procedure
- •3.5.4 Results of MDP
- •3.6 Balloon Dilatation
- •3.6.1 Indications for Balloon Dilatation
- •3.6.2 Anaesthesia for Balloon Dilatation
- •3.6.3 Surgical Technique with 2 mm or 3 mm Balloon for Incomplete Stenosis
- •3.6.3.1 Post-Operative Care
- •3.6.3.2 Complications
- •3.6.3.3 Results
- •3.6.4.1 Post-Operative Care
- •3.6.4.2 Results
- •3.6.4.3 Complications
- •3.7 Stent Placement
- •3.7.1 Indications for Stent Placement
- •3.7.3 Surgical Technique for Stent Placement
- •3.7.5 Results of Stent Placement
- •References
- •4. Minimally Invasive Corneal Surgery
- •4.1 Penetrating Keratoplasty
- •4.1.1 Introduction
- •4.1.2 Indications
- •4.1.3 Preoperative Evaluation of the Keratoplasty Patient
- •4.1.4 Preparation for Penetrating Keratoplasty
- •4.1.4.1 Eyelid Speculum
- •4.1.4.2 Scleral Fixation Rings
- •4.1.4.3 Large and Fine-Tipped Needle Holder
- •4.1.4.4 Toothed Forceps
- •4.1.4.5 Trephine Blades
- •4.1.4.6 Radial Marker
- •4.1.4.7 Cornea Punch
- •4.1.4.8 Cutting Block
- •4.1.4.9 Scissors
- •4.1.4.10 Cannulas and Blades
- •4.1.5 Preoperative Medications
- •4.1.6 Penetrating Keratoplasty Surgical Procedure
- •4.1.6.1 Placement of the Scleral Fixation Ring
- •4.1.6.2 Marking of the Host Cornea
- •4.1.6.3 Sizing of the Trephine
- •4.1.6.4 Trephination of the Host Cornea
- •4.1.6.5 Trephination of the Donor Cornea
- •4.1.6.6 Removal of the Host Cornea
- •4.1.6.7 Placement of the Donor Cornea Tissue in the Host Stromal Bed
- •4.1.6.8 Placement of the Cardinal Sutures
- •4.1.6.9 Completion of Suturing
- •4.1.6.10 Suture Techniques
- •4.1.6.11 Subconjunctival Medications
- •4.1.7 Intraoperative Complications
- •4.1.7.1 Scleral Perforation
- •4.1.7.2 Damage to the Donor Button
- •4.1.7.4 Posterior Capsule Rupture
- •4.1.7.5 Vitreous Loss
- •4.1.7.6 Anterior Chamber Hemorrhage
- •4.1.7.7 Choroidal Hemorrhage
- •4.1.8 Postoperative Management
- •4.1.8.1 Postoperative Immunosuppressive Regimen
- •4.1.9 Postoperative Complications
- •4.1.9.1 Wound Leaks
- •4.1.9.2 Epithelial Defects
- •4.1.9.3 Suture-Related Problems
- •4.1.9.4 Increased Intraocular Pressure
- •4.1.9.5 Post-Keratoplasty Astigmatism
- •4.1.10.1 Wedge Resections and Compression Sutures
- •4.1.10.2 Relaxing Incisions
- •4.1.10.3 LASIK
- •4.1.10.4 Photorefractive Keratectomy with Mitomycin C
- •4.1.11 Corneal Allograft Rejection
- •4.1.11.1 Host Risk Factors
- •4.1.11.2 Vascularized Corneas
- •4.1.11.3 Prior Graft Loss
- •4.1.11.4 Graft Diameter
- •4.1.11.5 Anterior Synechiae
- •4.1.11.6 Previous Intraocular Surgery
- •4.1.11.7 Herpes Simplex
- •4.1.12 Treatment of Allograft Rejection
- •4.1.13 Large Diameter Penetrating Keratoplasty
- •4.1.14 Summary
- •References
- •4.2 Descemet’s Stripping Endothelial Keratoplasty
- •4.2.1 Introduction
- •4.2.2 Descemet’s Stripping Endothelial Keratoplasty Surgical Technique
- •4.2.2.1 Donor Cornea Preparation
- •4.2.2.2 Host Cornea Preparation
- •4.2.2.3 Insertion of the Donor Cornea
- •4.2.3 Postoperative Medications
- •4.2.4 Donor Dislocation Risks
- •4.2.5 Repositioning Donor Tissue
- •4.2.6 Treatment of Rejection Episodes
- •4.2.7 Visual and Refractive Outcomes
- •4.2.8 Other Complications
- •4.2.9 Summary
- •References
- •4.3 Pterygium
- •4.3.1 Introduction
- •4.3.2 Treatment of Pterygium
- •4.3.3 Surgical Technique
- •4.3.3.1 Removal of the Pterygium
- •4.3.3.2 Harvesting the Conjunctival Autograft
- •4.3.3.3 Securing the Conjunctival Autograft
- •4.3.3.4 Fibrin Glue vs. Nylon Sutures
- •4.3.4 Postoperative Management
- •4.3.5 Recurrent Pterygium
- •4.3.6 Other Techniques in Pterygium Removal
- •4.3.6.1 Bare Scleral Technique
- •4.3.6.2 Adjunctive Agents
- •Mitomycin C
- •Beta-Irradiation
- •4.3.6.3 Amniotic Membrane Transplantation
- •4.3.7 Complications in Pterygium Removal
- •4.3.8 Summary
- •References
- •5. Minimally Invasive Refractive Surgery
- •5.1 Trends in Refractive Surgery
- •5.2 Introduction
- •5.3 Cornea Refractive Surgery
- •5.3.1 Laser In Situ Keratomileusis (LASIK)
- •5.3.1.1 Advances in Flap Creation Technology
- •Microkeratomes
- •Femtosecond Laser
- •5.3.1.2 Technological Advances in Laser Delivery Platforms
- •5.3.1.3 Faster Excimer Lasers
- •5.3.1.4 Reduction of Collateral Thermal Tissue Damage
- •5.3.1.5 Advanced Eye Trackers
- •5.3.2 PRK and Advanced Surface Ablations (ASA)
- •5.3.2.1 Decrease Thermal Load on the Cornea
- •5.3.2.2 Use of Wound-Healing Modulators
- •5.3.2.3 Trend Towards EPI-LASIK
- •5.3.3 Summary
- •5.4 Intraocular Refractive Surgery
- •5.4.1 Phakic Intraocular Lens Surgery
- •5.4.1.1 Advances in Diagnostic Equipment
- •5.4.1.2 Types of Phakic Intraocular Lens
- •5.4.1.3 Kelman-Duet Phakic Intraocular Lens
- •Lens Design
- •Surgical Technique
- •Pre-Operative Preparation
- •Operative Procedure
- •Post-Operative Care
- •Results
- •Refractive Outcomes
- •Corneal Endothelium
- •5.4.1.4 Visian Implantable Collamer Lens
- •Lens Design
- •Surgical Technique
- •Pre-Operative Preparation
- •Operative Procedure
- •Post-Operative Care
- •5.4.1.5 Results
- •5.4.2 Summary
- •5.5 Lens and Cataract Surgery
- •5.5.2 The Ideal MICS Intraocular Lens
- •5.5.2.1 Aspheric Intraocular Lenses
- •5.5.2.2 Toric Intraocular Lenses
- •5.5.2.3 ACRI.LISA 366D and ACRI.LISA TORIC 466TD
- •Lens Design
- •5.5.2.4 Surgical Technique
- •Operative Procedure
- •Post-Operative Care
- •5.5.2.5 Results
- •5.5.3 Summary
- •5.6 The Future: Beyond the Horizon of Refractive Surgery Today
- •Reference
- •6. Minimally Invasive Strabismus Surgery
- •6.1 Introduction
- •6.2 Nonsurgical Treatment
- •6.4 Rectus Muscle Procedures
- •6.4.1 MISS Rectus Muscle Recession
- •6.4.2 MISS Rectus Muscle Plication
- •6.4.3 Parks’ Rectus Muscle Recession
- •6.4.4 Parks’ Rectus Muscle Plication
- •6.4.5 MISS Rectus Muscle Posterior Fixation Suture
- •6.4.7 MISS Rectus Muscle Repeat Surgery
- •6.4.8 MISS Rectus Muscle Transposition Surgery
- •6.5 Oblique Muscle Procedures
- •6.5.1 MISS Inferior Oblique Muscle Recession
- •6.5.2 MISS Inferior Oblique Muscle Plication
- •6.5.3 MISS Superior Oblique Muscle Recession
- •6.5.4 MISS Superior Oblique Muscle Plication
- •6.5.6 Mühlendyck’s Partial Posterior Superior Oblique Tenectomy for Congenital Brown’s Syndrome
- •6.6 Postoperative Handling
- •6.7.1 Intraoperative Complications
- •6.7.2 Postoperative Complications
- •6.8 Suggestions on How to Start Doing MISS
- •6.8.1 Instruments Suitable for MISS
- •6.8.2 Suture Materials Used for MISS
- •6.8.3 General Remarks Regarding MISS Procedures
- •6.8.4 MISS Dose–Response Relationships
- •References
- •7. Minimally Invasive Iris Surgery
- •7.1 Instrumentation
- •7.2 Sutures
- •7.3 Surgical Principles of Iris Suturing
- •7.3.1 Mobilization
- •7.3.2 Intraocular Suturing and Knot Tying
- •7.3.3 Reattachment of Iris to Sclera
- •7.3.4 Pupil Repair
- •7.3.5 Adjunctive Pupil Repair Techniques
- •References
- •8. Minimally Invasive Glaucoma Surgery
- •Introduction
- •8.1.1 Introduction to Deep Sclerectomy
- •8.1.2 Anesthesia
- •8.1.3 Surgical Technique
- •8.1.3.1 Preparation
- •8.1.3.3 Deep Flap Preparation
- •8.1.3.5 Peeling of Schlemm’s Canal and Juxtacanalicular Meshwork
- •8.1.3.6 Drainage Device
- •8.1.3.7 Wound Closure
- •8.1.4 Postoperative Management and Medication
- •8.1.4.1 Medication
- •8.1.4.2 Management
- •8.1.5 Adjunctive Treatments
- •8.1.5.1 Bleb Needling
- •8.1.5.2 Nd:YAG Goniopuncture
- •8.1.6 Complications and Management
- •8.1.6.1 General
- •8.1.6.2 Perioperative Complications
- •8.1.6.3 Early Postoperative Complications
- •8.1.6.4 Late Postoperative Complications
- •Open-Angle Glaucoma
- •Pigmentary Glaucoma
- •Pseudoexfoliation Glaucoma
- •Aphakic Glaucoma
- •Sturge–Weber Syndrome
- •Glaucoma Secondary to Uveitis
- •Congenital and Juvenile Glaucoma
- •Narrow-Angle Glaucoma
- •Posttrauma Angle-Recession Glaucoma
- •Neovascular Glaucoma
- •Narrow-Angle Glaucoma in a Young Patient
- •Pseudophakic Glaucoma with an A/C IOL
- •8.2.1.4 Preoperative Considerations
- •8.2.2 Anesthesia
- •8.2.4 Postoperative Management and Medication
- •8.2.5 Outcomes and Comparison with Other Techniques
- •8.2.6 Complications and Management
- •8.2.6.1 General
- •8.2.6.4 Summary and Key Points
- •References
- •8.3 New Minimally Invasive, Sclerothalamotomy Ab Interno Surgical Technique
- •8.3.1 Introduction to the Sclerothalamotomy Ab Interno
- •8.3.1.1 Indications for the Sclerothalamotomy Ab Interno
- •8.3.2 Anesthesia
- •8.3.3 Surgical Technique
- •8.3.3.1 Preparation
- •8.3.3.2 Diathermy Probe Insertion
- •8.3.4 Postoperative Management and Medication
- •8.3.5 Outcomes and Comparison with Other Techniques
- •8.3.6 Complications and Management
- •8.3.6.1 General
- •8.3.6.3 Conclusions
- •References
- •Type of Glaucoma
- •Stage of Glaucoma
- •Combined Surgery
- •8.4.2 Anesthesia
- •8.4.3 Surgical Technique
- •8.4.3.1 Preparation
- •8.4.3.2 Implantation of the Micro-Bypass Stent
- •8.4.4 Postoperative Management and Medication
- •8.4.5 Outcomes and Combination with Other Techniques
- •8.4.5.1 Trabecular Implant in Refractory Glaucoma Patients
- •8.4.6 Conclusions
- •References
- •9. Minimally Invasive Cataract Surgery
- •10. Minimally Invasive Vitreoretinal Surgery
- •10.1 Introduction
- •10.2 Microincision Vitrectomy
- •10.2.1 Models of Wound Architecture
- •10.2.2 Vitrectomy
- •10.2.3 Adjuncts
- •10.2.4 Common Surgical Techniques
- •10.2.4.1 Macular Surgery
- •10.2.4.2 Proliferative Diabetic Retinopathy
- •10.2.4.3 Retinal Detachment
- •10.2.4.4 Pediatric Vitreoretinal Surgery
- •10.2.5 Complications
- •10.2.6 Future Developments in Minimally Invasive Vitrectomy
- •10.3 Endoscopic Vitreoretinal Surgery
- •10.3.1 Introduction
- •10.3.2 History and Development of Endoscopic Ophthalmic Surgery
- •10.3.3 The Endoscope
- •10.3.4 Applications of Intraocular Endoscopy
- •10.3.4.1 Media Opacity
- •10.3.4.3 PVR and Subretinal Surgery
- •10.3.4.4 Retained Lens Fragments
- •10.3.4.5 Anterior and Retrolental Vitrectomy in Malignant Glaucoma
- •10.3.4.5 Sutured IOL and ECP
- •10.3.5 Limitations and Challenges
- •10.4 Future Directions of Minimally Invasive Vitreoretinal Surgery
- •References
- •INDEX
98 |
J. L. Alio et al. |
5.3 Cornea Refractive Surgery
5.3.1Laser In Situ Keratomileusis (LASIK)
LASIK is currently the most popular refractive surgery technique. Since the introduction of LASIK in 1992, the goal of all refractive surgeons performing LASIK is to achieve predictable and accurate results while at the same time minimising the amount of tissue ablation and improving safety of the procedure. The LASIK procedure consists of two key parts, corneal flap creation and laser ablation of the stromal bed. Hence, the above-mentioned goals of refractive surgeons can be accomplished by technological advancements in microkeratome/flap creation technology and improvements in LASIK delivery systems. The trends in LASIK are:
1.Decreasing the amount of tissue ablation per dioptre treated
2.Increasing the predictability of LASIK
3.Reducing the incidence of complications associated with LASIK
4.Decreasing the time required for the procedure
5.Increasing the optical quality post-operatively
5.3.1.1 Advances in Flap Creation Technology
The creation of a corneal flap prior to excimer laser ablation of the stromal bed is a key feature of LASIK. This is also perhaps the riskiest step during LASIK as complications during flap creation like buttonholes, partial or free flaps can be devastating. The thickness of the flap is also an important factor. A thinner corneal flap will result in a thicker stromal bed prior to excimer laser ablation. This means that more corneal tissue can be ablated while at the same time maintaining a safe residual stromal bed after ablation. Hence, higher degrees of refractive error may be treated. Furthermore, the risk of corneal ectasia may be reduced with a thicker residual stromal bed.
Currently, corneal flaps can be created by using a microkeratome or by femtosecond laser. Microkeratomes use blades to cut the corneal stroma while femtosecond laser utilises laser to create bubbles which are delivered in a raster pattern across the cornea to create an interface cut and then a side cut. The flap is
then lifted with blunt dissection using a spatula or similar instrument. In both methods, technologies have been developed with the goals of creating safer, thinner and more precise corneal flaps.
Microkeratomes
The first commercially available microkeratome was the Automated Corneal Shaper (ACS), manufactured by Bausch & Lomb. It was a good unit in the hands of an experienced surgeon but had inherent problems that increased the risk of complications. The ACS has different parts which must be taken apart during the sterilisation process and subsequently reassembled. Errors in reassembly may result in major complications during flap creation. Second-generation microkeratomes include Draeger Lamellar Keratome (Storz Instrument GmbH, Heidelberg, Germany) and Microprecision test model (Microprecision Instrument Company, Inc, Phoenix, Az). Hoffman et al. compared the three second-gener- ation microkeratomes and showed that the three systems produced irregular surfaces with chatter lines and the variability in flap thickness was over 20 mm in all three systems [25].
Third-generation microkeratomes include the Hansatome microkeratome (Bausch and Lomb Surgical) which was commercially available in 1997. The Hansatome microkeratome incorporated many design and functional improvements over the ACS microkeratome which aims to improve the safety of the instrument to minimise intraoperative flap complications. Studies by Walker et al. and Jacobs et al. confirmed that intraoperative flap complications are less likely to occur with the Hansatome microkeratome than with the ACS microkeratome [29, 64]. The Hansatome microkeratome is available with the 200, 180 or 160 mm head. Hence, theoretically, the minimum flap thickness possible with the Hansatome microkeratome was 160 mm. But in one study, the mean flap thickness created with the Hansatome microkeratome using a 160 mm head resulted in a mean flap thickness of 97 mm ± 18 (SD) (range 65–163 mm). Thus, while the third-generation microkeratomes afford greater safety compared to the earlier microkeratomes, the flaps created are not as precise as is demanded by refractive surgeons today.
Today, a wide range of new microkeratomes are available to the refractive surgeons, each promising safer
5 Minimally Invasive Refractive Surgery |
99 |
and more precise corneal flap creation. These newer microkeratomes include the Amadeus II microkeratome (Advanced Medical Optics), Zyoptix XP microkeratome (Bausch & Lomb), Moria’s One Use-Plus and M2 microkeratomes, BD K-4000 microkeratome (Becton Dickinson), Nidek’s MK-2000 microkeratome and the Carriazo-Pendular microkeratome (SCHWIND eye-tech solutions). Most of these microkeratomes are available with heads designed to create either 120 or 130 mm flaps. Some of the microkeratomes, for example the Carriazo-Pendular microkeratome, is available with a 90-mm cutting head (Fig. 5.1). Comparison of the Hansatome and Zyoptix XP microkeratome in one study showed that although the two microkeratomes produced flaps of similar mean thickness, the Zyoptix
Fig. 5.1 The Carriazo-Pendular microkeratome
XP showed significantly less variation in flap thickness than the Hansatome. The Zyoptix XP microkeratome was less affected by measurable pre-operative variables such as pre-operative spherical equivalent of the eye and was closer to nominal labelling [52]. While current available microkeratomes produce corneal flaps which are more precise than third-generation microkeratomes, variations in flap thickness are still present [59].
Recently, Moria has launched its One Use-Plus SBK (Sub Bowman’s Keratomileusis) microkeratome (Fig. 5.2) which is designed to create ultra thin flaps which are comparable to flaps created by femtosecond laser. While conventional LASIK flap has a thickness of 120–180 mm, the One Use-Plus SBK is designed to create thinner flaps of between 90 and 110 mm. The cutting of thinner flaps will preserve more of the integrity of the cornea, thereby lowering the risk of ectasia while at the same time provide greater comfort to the patient post-LASIK. This microkeratome is also extremely fast compared to existing microkeratomes, thereby reducing suction time. The microkeratome is also reported by the company to produce smoother stromal beds (Fig. 5.3). This may lead to a reduction in the induction of post-operative corneal aberrations. But more studies will be needed to assess its performance.
Femtosecond Laser
The introduction of the femtosecond laser to create a corneal flap, the first and most popular being the Intralase® femtosecond laser (Advanced Medical Optics), was a significant advancement in LASIK technology. This “bladeless” procedure involves the creation of cavitation bubbles by laser in a raster pattern across the cornea to create an interface which can then be lifted by a blunt dissection instrument. While
Fig. 5.2 The Moria One Use-Plus SBK microkeratome
100 |
J. L. Alio et al. |
Fig. 5.3 Scanning electron microscope image of a stromal bed after creation of a flap by the Moria One Use-Plus SBK microkeratome
the femtosecond laser is a relatively new technology, improvements in technology can be observed over this short time period. The trends in femtosecond laser technology include:
1.Ability to create thinner flaps
2.Decreasing the amount of energy delivered to the cornea
3.Decreasing the time required for the procedure with increased precision
4.Decreasing the biomechanical impact of the flap creation
5.Reducing trauma (including changes in intraocular pressures during surgery)
The main advantage of using a femtosecond laser for flap creation is the greater degree of control and monitoring before and during flap creation compared to microkeratomes. The size, position of the flap and position of the hinge can be determined pre-operatively. Furthermore, since the corneal flap is only created after the flap is mechanically lifted, should a complication occur during the raster pattern delivery, the process can technically be “reversed” by waiting a few weeks before performing the procedure again. This affords greater safety and almost eliminates the risk of flap complications like partial flaps or buttonholes, especially for high-risk eyes, e.g. eyes with steep corneas.
Intralase® is also able to create thinner flaps of up to 90 mm compared to conventional microkeratomes. Several studies have showed that the flaps created by
Intralase® are more precise and predictable compared to conventional microkeratomes [13, 31]. The precision and predictability of the Intralase® machine allows the refractive surgeon to better plan and invidualise the LASIK surgery for their patients, especially patients with borderline corneal thickness. At the same time, ability to create thinner flaps will also help preserve the structural integrity of the cornea and lower the risk of corneal ectasia.
We compared the flaps created by the Intralase® FS laser, the Moria M2 microkeratome (Moria, Antony, France) and the Carriazo-Pendular microkeratome (Schwind eye-tech solutions, Kleinostheim, Germany). Several mechanical microkeratomes create flaps that are thinner at the centre than the periphery (meniscusshaped configuration). Analysis of the flaps created by the Moria M2 microkeratome, which is an applanation microkeratome, using the very high-frequency (VHF) eye scanner, Artemis 2 (Ultralink LLC, St Petersburg, Fla) with a 50-MHz probe confirmed this. This is because the plate induces an excessive compression of the peripheral tissue of the cornea with posterior indentation of the central area (Fig. 5.4a). The CarriazoPendularmicrokeratome,anindentationmicrokeratome, produced an almost planar configuration with slight thickening in the inferior area (Fig. 5.4b). The flaps created by the Intralase® FS laser were also more homogeneous, showing a planar or almost-planar thickness flap profile in most cases, compared to the M2 microkeratome (Fig. 5.4c) A meniscus-shaped flap behaves as an additional optical element of the ocular system, introducing new higher-order aberrations and modifying the predictability of the second-order corrections. In our study, the corneal spherical-like RMS was higher in the M2 group compared to the other two groups.
Studies have also compared the visual quality and amount of corneal aberrations after LASIK with Intralase® and conventional microkeratomes. Durrie et al. compared eyes which have undergone LASIK with Intralase® and the Hansatome microkeratome. His study showed statistically better UCVA and manifest refractive outcomes after LASIK with the IntraLase femtosecond laser may be the result of reduced postoperative astigmatism and trefoil induced by the machine [22]. Studies have also demonstrated that the Intralase® induces less post-operative aberrations compared to conventional microkeratomes [39, 61].
The main disadvantage of the femtosecond laser is the longer time required to create the raster pattern.
5 Minimally Invasive Refractive Surgery |
101 |
||||
a |
|
|
|
However, with newer versions, the process is much |
|
|
|
|
|||
|
|
|
|
quicker, albeit still slower than conventional microker- |
|
|
|
|
|
atomes. For example, the fourth-generation Intralase® |
|
|
|
|
|
machine has a frequency of 150 kHz. This is 15 times |
|
|
|
|
|
faster than the original Intralase machine which has a |
|
|
APPLANATION MICROKERATOME |
frequency of 10 kHz. |
|||
|
|
|
|
Newer systems have higher repetition rates and use |
|
b |
|
|
|
lower energy levels to enable faster flap creation and to |
|
|
|
|
|
reduce the amount of thermal energy delivered to the |
|
|
|
|
|
cornea, thereby reducing the incidence of Transient |
|
|
|
|
|
Light Sensitivity Syndrome. For example, the Zeiss |
|
|
INDENTATION MICROKERATOME |
VisuMax® has a repetition rate of 200 kHz and a typi- |
|||
|
cal pulse energy of less than 300 nJ per laser spot. |
||||
|
|
|
|
||
|
|
|
|
Innovations in the optics used in the Zeiss VisuMax® |
|
|
|
|
|
enables increased focusing precision of the laser spots |
|
|
|
|
|
delivered (Fig. 5.5) to the cornea. |
|
|
|
|
|
Other technological advances can be seen in femto- |
|
|
|
|
|
second laser platforms. The trend in these new innova- |
|
|
|
|
|
tions is in line with the overall aim of minimal invasive |
|
|
|
|
|
surgery. For example, the Zeiss VisuMax® uses spher- |
|
|
|
|
|
ically curved contact glass to applanate the eye during |
|
|
Laser beam |
the docking procedure (Fig. 5.6). By this method, the |
|||
c |
VisuMax® creates a spherical contact interface only |
||||
|
|
|
|||
|
|
|
|
with the corneal surface and limbus, the cornea is min- |
|
|
|
|
|
imally applanated during this step and the intraocular |
|
|
|
|
|
pressure rise is reduced. Hence, patient discomfort dur- |
|
|
|
|
|
ing this step is markedly reduced. Furthermore, suc- |
|
|
|
|
|
tion is only applied during the laser procedure, thereby |
|
|
FEMTOSECOND SYSTEM |
minimising the time the eye is under suction. As the |
|||
|
|
|
|
sclera is not touched during this procedure, compli- |
|
Fig. 5.4 Schematics showing the lamellar cut procedure using |
cations related to conjunctival trauma, e.g. conjunc- |
||||
different devices for lamellar keratotomy. (a) Lamellar cut with |
tival oedema, conjunctival haemorrhage, are avoided. |
||||
an applanation microkeratome (Moria M2). (b) Lamellar cut |
|||||
Another advantage of this method is that the flap is |
|||||
with an indentation microkeratome (Carriazo-Pendular). (c) |
|||||
created while the eye is in a “relaxed” compared to an |
|||||
Lamellar photodisruption of the interface by the femtosecond |
|||||
laser (Intralase) |
eye with a flattened cornea. Hence, the flap diameter |
||||
Standard Optics |
Zeiss Optics |
|
Fig. 5.5 Diagram showing |
|
|
|
|
Depth |
Depth |
||||||
|
|
|
|
Accuracy |
Accuracy |
|
|
|
|
|||
how the optics used in the |
Spot |
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
Spot |
||||
Zeiss VisuMax® increases |
Diameter |
|
|
|
|
|
|
|
Diameter |
|||
|
|
|
|
|
||||||||
the precision of each laser |
|
|
|
|
|
|
|
|
|
|
|
|
spot by increasing the depth |
|
|
|
|
|
|
|
|
|
|
|
|
accuracy and reducing the |
|
|
|
|
|
|
|
|
|
|
|
|
spot diameter of each laser |
|
|
|
|
|
|
|
|
|
|
|
|
spot |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
